STOCK TITAN

Cryomass Technologies Inc - CRYM STOCK NEWS

Welcome to our dedicated page for Cryomass Technologies news (Ticker: CRYM), a resource for investors and traders seeking the latest updates and insights on Cryomass Technologies stock.

About CryoMass Technologies Inc.

CryoMass Technologies Inc. (OTCQB: CRYM) specializes in developing and licensing advanced cryogenic refinement systems for trichome-rich crops such as cannabis and hemp. Utilizing patented cryogenic processes, the company’s innovative technologies, including the CryoSift Separator™, enable cultivators and processors to isolate and preserve high-value resin glands (trichomes) containing cannabinoids and terpenes. This not only enhances product quality but also significantly reduces biomass volume, leading to cost savings in storage, handling, and transportation.

Core Business Model

CryoMass generates revenue through a combination of equipment sales, non-exclusive patent licensing agreements, and recurring processing fees based on biomass volume. Its flagship product, the CryoSift Separator™, is designed to streamline post-harvest operations for cultivators and processors, offering a scalable solution that integrates seamlessly into existing workflows. By reducing biomass volume by up to 80% and preserving potency and terpene profiles, CryoMass delivers tangible operational efficiencies and cost advantages to its clients.

Industry Context and Competitive Landscape

The cannabis and hemp industries are characterized by rapid growth, increasing competition, and stringent regulatory environments. Post-harvest processing, a critical step in the supply chain, often faces inefficiencies and high costs. CryoMass addresses these challenges with its proprietary cryogenic technology, which not only enhances extraction efficiency but also minimizes waste and optimizes logistics. Key competitors include traditional processing methods and other technology providers; however, CryoMass differentiates itself through its patented processes and focus on preserving the integrity of high-value trichomes.

Technological Innovation

At the heart of CryoMass’s value proposition is its cryogenic refinement technology. The CryoSift Separator™ employs liquid nitrogen to reduce biomass and isolate intact trichomes, which are rich in cannabinoids and terpenes. This process yields a superior concentrate, CryoSift™, which offers enhanced extractability and longer shelf life compared to unprocessed biomass. The technology’s ability to reduce biomass volume dramatically lowers operational costs, making it a transformative solution for both cultivators and processors.

Market Significance

CryoMass plays a pivotal role in the evolving cannabis and hemp industries by addressing critical pain points in post-harvest processing. Its technology enables clients to achieve higher yields, better product quality, and significant cost savings, thereby enhancing their competitiveness in the market. Furthermore, the company’s recurring revenue model through licensing and processing fees underscores its long-term commitment to innovation and customer success.

Conclusion

CryoMass Technologies Inc. stands out as a pioneer in cryogenic biomass refinement, offering cutting-edge solutions that redefine post-harvest processing for trichome-rich crops. With its patented technologies, the company provides a unique blend of efficiency, quality, and cost-effectiveness, positioning itself as a valuable partner for cultivators and processors navigating the challenges of a competitive and regulated industry.

Rhea-AI Summary

CryoMass Technologies Inc. (OTCQB: CRYM) has announced the sale of a CryoSift Separator™ production model to Tribe Collective, with shared usage rights granted to Choctaw Processing in the Oklahoma cannabis market. The deal includes non-exclusive patent license agreements with both companies for at least five years.

The transaction structure combines one-time revenue from equipment sale and recurring processing fees based on biomass volume, with potential recurring revenues exceeding $1,000,000 annually. The sale was facilitated through financing from NEC Financial Services,

This shared-usage model demonstrates CryoMass's ability to create value for multiple operators within competitive markets by enabling cost reductions and improved extraction efficiency. The technology adoption by established operators validates its potential to transform harvest and post-harvest operations while establishing a recurring revenue model for CryoMass.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

CryoMass Technologies announced the sale of its second CryoSift Separator™ for $1.2 million to LEEF Brands, a major vertically integrated cannabis company in California. This sale is part of a multi-party Equipment Lease and Non-Exclusive Patent License agreement facilitated by a Non-Dilutive Financing Agreement with CRYM Co-Invest GP. The partnership highlights LEEF's commitment to innovation and efficiency in biomass refinement, aligning with CryoMass's pioneering cryogenic technology. This collaboration is a significant milestone for CryoMass, reinforcing its position in the cannabis industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
50.61%
Tags
partnership
-
Rhea-AI Summary

CryoMass Technologies announced the sale of its first CryoSift Separator™ production model for CAD$1.62 million, to be deployed in Canada. The sale is part of a multi-party Equipment Lease and Non-Exclusive Patent License agreement, which will also generate recurring revenue from processing fees. The new modular system dramatically reduces biomass volume by 65% and enhances both performance and versatility. The buyer has 60 days to complete the payment. This marks a significant milestone in CryoMass's growth strategy and aims to introduce its cryogenic technology to Canada's mature cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
Rhea-AI Summary
CryoMass Technologies Inc. has reached an agreement with CRYM Co-Invest GP to sell up to five CryoSift Separator™ Units for a total of up to US$6 million. The innovative financing structure provides growth capital to CryoMass while enabling wider deployment of the Company's processing technology. The funding arrangement will be non-dilutive to CryoMass shareholders, while providing a recurring revenue stream from processing fees charged to Clients. Access to capital has been an ongoing challenge for prospective Clients working in the cannabis industry due to federal prohibition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32.5%
Tags
none
-
Rhea-AI Summary
CryoMass signs license agreement with RubberRock Inc. for large-scale cannabinoid production, guaranteeing at least $3 million in annual royalties. CryoMass aims to scale its disruptive technology and increase revenue potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
partnership
-
News
Rhea-AI Summary
CryoMass Technologies Inc. announces successful transition to commercial processing phase with its Trichome Separation Beta unit. The company has achieved a major milestone by designing and constructing an industrial-scale Beta system. CryoMass expects to receive scheduled payments from RedTape over the next 12 months and is engaged in discussions for market expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.38%
Tags
none
Rhea-AI Summary

CryoMass Technologies Inc. (OTCQX: CRYM) announced the signing of a multi-state license agreement with RedTape Core Partners LLC on January 18, 2023. This follows the delivery of CryoMass' Trichome Separation unit to RedTape's facility in Monterrey, California, for beta testing.

The licensed agreement includes a total investment of US$10.2 million over 2023 for the deployment of 12 Trichome Separation systems. The partnership aims to enhance hemp and cannabis processing capabilities across California, New York, New Jersey, Florida, and Pennsylvania.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
-
Rhea-AI Summary

CryoMass Technologies (OTC: CRYM) announced the Canadian Intellectual Property Office granted it a patent (#3064896) for a novel cryogenic separation process for plant material, valid until 2039. This patent follows similar protections granted in the U.S. and China, effective until 2038. CEO Christian Noël emphasized the significance of this patent in the booming $50 billion cannabis/hemp industry and its potential applications across agriculture. The company aims to enhance its global patent portfolio, including upcoming applications in the European Union.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.05%
Tags
none
-
Rhea-AI Summary

CryoMass Technologies has initiated real-time trials for its patented cryogenic system designed for extracting high-value elements from hemp and cannabis plants. The system, measuring 160 square feet and operating with ultra-cold liquid nitrogen, aims to enhance efficiency and quality in cannabinoid capture. Preliminary results show throughput rates of 400-600 kg/hour and a capture rate of 96-97%. The company believes the device offers significant advantages over conventional methods, which typically incur a loss of around one-third of cannabinoids.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none
Rhea-AI Summary

CryoMass Technologies Inc. has initiated real-time trials of its patented cryogenic system for hemp and cannabis extraction. The equipment, which measures 160 square feet and operates at ultra-cold temperatures, aims to maximize cannabinoid capture and efficiency. Preliminary results show a throughput of 400-600 kg/hour and a cannabinoid capture rate between 96% and 97%. The system promises significant time and cost savings over traditional methods, potentially benefiting large-scale cultivators and processors of botanicals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none

FAQ

What is the current stock price of Cryomass Technologies (CRYM)?

The current stock price of Cryomass Technologies (CRYM) is $0.0468 as of February 28, 2025.

What is the market cap of Cryomass Technologies (CRYM)?

The market cap of Cryomass Technologies (CRYM) is approximately 5.4M.

What does CryoMass Technologies Inc. do?

CryoMass Technologies Inc. develops and licenses cryogenic refinement systems for cannabis and hemp, focusing on isolating high-value trichomes.

How does CryoMass generate revenue?

CryoMass generates revenue through equipment sales, patent licensing agreements, and recurring processing fees based on biomass volume.

What is the CryoSift Separator™?

The CryoSift Separator™ is CryoMass’s flagship product, using patented cryogenic processes to isolate and preserve trichomes while reducing biomass volume.

What are the benefits of CryoMass’s technology?

CryoMass’s technology enhances extraction efficiency, preserves product potency, reduces biomass volume, and lowers operational costs for clients.

Who are CryoMass’s primary customers?

CryoMass primarily serves cannabis and hemp cultivators and processors seeking to optimize post-harvest operations and improve product quality.

How does CryoMass differentiate from competitors?

CryoMass differentiates through its patented cryogenic technology, which isolates intact trichomes, reduces biomass volume, and preserves terpene profiles.

What industries does CryoMass serve?

CryoMass serves the cannabis and hemp industries, with potential applications for other trichome-rich crops in the future.

What challenges does CryoMass address in the cannabis industry?

CryoMass addresses inefficiencies in post-harvest processing, high operational costs, and the need for high-quality, scalable solutions in the cannabis industry.
Cryomass Technologies Inc

OTC:CRYM

CRYM Rankings

CRYM Stock Data

5.35M
199.87M
15.72%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Denver